Close Menu

credit rating

The ratings agency has affirmed BBB ratings for Thermo Fisher's long term issuer default rating, senior notes, and bank revolving credit facility.

The ratings firm noted Thermo Fisher's efforts to bring down its debt and said that the company could resume bolt-on acquisitions next year. 

The story has been updated with information about the pricing of the notes released by Agilent after the close of the market.

NEW YORK (GenomeWeb News) – Standard & Poor's on Thursday raised Life Technologies' corporate credit rating and the issue-level rating on the firm's secured and unsecured debt to BBB+.

NEW YORK (GenomeWeb News) – Fitch Ratings late on Tuesday affirmed several ratings of BBB+ for Agilent Technologies.

Morningstar said that the rating reflects its negative view of the genetic analysis instrument business and potential competitive pressure for Illumina.

The rating agency raised its outlook on Agilent to 'positive' from 'stable' due to "greater confidence in Agilent's operating and financial profile."

S&P cited Bio-Rad's "solid operating performance and cash flow generation" in announcing the upgrade.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.